Ampk (Amp Activated Protein Kinase) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
AMP-Activated Protein Kinase (AMPK) is a central metabolic sensor and regulator that maintains cellular energy homeostasis[1]. Often called the "cellular energy sensor," AMPK is activated in response to energy stress[2], when AMP/ATP ratios increase. In the nervous system, AMPK plays crucial roles in neuronal metabolism, autophagy, mitochondrial function, and neuroprotection—all processes central to neurodegenerative disease pathogenesis. [2:1]
AMPK serves as a critical link between metabolic dysfunction and neurodegeneration, making it an attractive therapeutic target for Alzheimer's disease, Parkinson's disease, Huntington's disease, and ALS[3]. [3:1]
AMPK is a heterotrimeric complex: [4]
The αβγ trimer forms 12+ tissue-specific combinations[4:1]. [5]
AMPK is activated by: [6]
Activated AMPK inhibits anabolic pathways and stimulates catabolic pathways including autophagy. [7]
AMPK isoforms are differentially expressed in the brain: [8]
AMPK serves as the cellular energy thermostat: [9]
AMPK is a key autophagy initiator: [10]
AMPK maintains mitochondrial health:
AMPK influences synaptic function:
AMPK dysregulation in AD[5:1]:
AMPK activators show promise in AD models by:
AMPK activation provides neuroprotection in PD models through:
The role of AMPK in HD is complex, with both protective and detrimental effects depending on context.
In ALS:
AMPK in MS:
The study of Ampk (Amp Activated Protein Kinase) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Hardie DG, et al. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol. 2012. ↩︎
Herzig S, Shaw RJ. AMPK: guardian of metabolism and mitochondrial homeostasis. Nat Rev Mol Cell Biol. 2018. ↩︎ ↩︎
Marinangeli C, et al. AMPK as a therapeutic target for neurodegenerative diseases. Curr Neuropharmacol. 2020. ↩︎ ↩︎
Hardie DG. AMPK: positive and negative regulation by upstream kinases. Int J Mol Sci. 2023. ↩︎ ↩︎
Vingtdeux V, et al. AMPK is abnormally activated in Alzheimer's disease. Acta Neuropathol Commun. 2013. ↩︎ ↩︎
Greco SJ, et al. AMPK as a therapeutic target in Parkinson's disease. J Mol Neurosci. 2019. ↩︎ ↩︎
Ju TC, et al. AMPK activation in Huntington's disease. Neurobiol Dis. 2014. ↩︎ ↩︎
Wang Y, et al. AMPK and autophagy in neurodegeneration. Cell Mol Neurobiol. 2020. ↩︎ ↩︎
Zhou G, et al. Metformin and AMPK in neuroprotection. Neuropharmacology. 2019. ↩︎
Calvert JW, et al. Acute AMPK activation in ischemic brain. J Cereb Blood Flow Metab. 2020. ↩︎